Abstract |
Cough in respiratory diseases is attributed to the activation of airway C-fibers by inflammation. Inflammatory mediators can act on multiple receptors expressed in airway C-fibers, nonetheless, the action potential initiation in C-fibers depends on a limited number of voltage-gated sodium channel (NaV1) subtypes. We have recently demonstrated that NaV1.8 substantially contributes to the action potential initiation in the airway C-fiber subtype implicated in cough. We therefore hypothesized that the NaV1.8 blocker A-803467 inhibits cough. We evaluated the cough evoked by the inhalation of C-fiber activator capsaicin in awake guinea pigs. Compared to vehicle, intraperitoneal or inhaled A-803467 caused 30-50% inhibition of cough at the doses that did not alter respiratory rate. We conclude that the NaV1.8 blocker A-803467 inhibits cough in a manner consistent with its action on the C-fiber nerve terminals in the airways. Targeting voltage-gated sodium channels mediating action potential initiation in airway C-fibers may offer a means of cough inhibition that is independent of the stimulus.
|
Authors | M Brozmanova, S Svajdova, N Pavelkova, Y Muroi, B J Undem, M Kollarik |
Journal | Respiratory physiology & neurobiology
(Respir Physiol Neurobiol)
Vol. 270
Pg. 103267
(12 2019)
ISSN: 1878-1519 [Electronic] Netherlands |
PMID | 31398537
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019. Published by Elsevier B.V. |
Chemical References |
- A 803467
- Aniline Compounds
- Antitussive Agents
- Furans
- NAV1.8 Voltage-Gated Sodium Channel
- Sodium Channel Blockers
|
Topics |
- Action Potentials
(drug effects)
- Administration, Inhalation
- Aniline Compounds
(adverse effects, therapeutic use)
- Animals
- Antitussive Agents
(adverse effects, therapeutic use)
- Bronchi
(innervation)
- Cough
(drug therapy)
- Dose-Response Relationship, Drug
- Furans
(adverse effects, therapeutic use)
- Guinea Pigs
- Injections, Intraperitoneal
- Lung
(innervation)
- Male
- NAV1.8 Voltage-Gated Sodium Channel
(drug effects)
- Nerve Fibers, Unmyelinated
(drug effects)
- Presynaptic Terminals
(drug effects)
- Sodium Channel Blockers
(adverse effects, therapeutic use)
|